FDA DrugClass IINotable
FDA Recall: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphe
Description
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Hazard
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Remedy
1392 bottles
Related Recalls
2026-06-10 · FDA_DRUG
FDA Recall: Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett C
Lannett Company Inc.
2026-05-27 · FDA_DRUG
FDA Recall: Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Phil
Lannett Company Inc.